Evidence map›Paper›PMID 41455036›Full record

ArticleDiscover oncology2025

Explainable machine learning predicts overall survival in female bladder cancer patients after radical cystectomy.

Ming Yan Zhong, Xin Chang Zou, Pei Huang Chen

Abstract read
In one paragraph

Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ming Yan ZhongDepartment of Oncology, Pingxiang Second People's Hospital, Pingxiang, 337000, Jiangxi, China.
Xin Chang ZouDepartment of Urology, The second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330000, Jiangxi, China.
Pei Huang ChenDepartment of Urology, Anxi County Hospital, Quanzhou, 362000, Fujian, China. 260650672@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeDespite the higher incidence of bladder cancer in males, females face a disproportionately worse prognosis with more advanced disease. Accordingly, accurate survival prediction is crucial. This study sought to develop multiple machine learning models for predicting postoperative overall survival (OS) in female bladder cancer patients who have undergone radical cystectomy (RC). PATIENTS AND

methodsA retrospective analysis was conducted on female patients who underwent RC with postoperative pathological confirmation of bladder cancer in the SEER database from 2004 to 2022. These patients were randomly divided into a training set and an internal validation set at a 7:3 ratio. Additionally, 67 female bladder cancer patients from the Second Affiliated Hospital of Nanchang University were included as an external validation set. LASSO-Cox regression and Cox regression were used to identify independent prognostic factors for bladder cancer. Based on these factors, prediction models were constructed using five machine learning algorithms: Support Vector Machine (SVM), K-Nearest Neighbors (KNN), Gradient Boosting Decision Tree (GBDT), Random Forest (RF), and XGBoost. The predictive performance of the models was evaluated using the area under the receiver operating characteristic curve (AUC), accuracy, precision, F1 score, concordance index (C-index), calibration curves, and decision curve analysis. The SHapley Additive exPlanations (SHAP) method was employed to interpret the most impactful features of the best-performing model.

resultsThe study included a total of 4,603 patients. Lasso-Cox regression screening and Cox regression analysis revealed that T stage, N stage, age, tumor size, marital status, chemotherapy, and the number of examined lymph nodes (ELN) during surgery were significantly associated with the OS of female bladder cancer patients. Compared with other models, GBDT demonstrated superior discriminative ability in predicting 1-year, 3-year, and 5-year survival rates (1-year AUC(95%CI) = 0.771(0.742-0.801), 3-year AUC(95%CI) = 0.757(0.730-0.783), 5-year AUC(95%CI) = 0.745(0.721-0.770)), along with higher prediction accuracy, precision, C-index and F1 score. The calibration curve and decision curve analysis (DCA) confirmed the excellent predictive accuracy and clinical benefits of the GBDT model. These results were also validated in the external validation cohort. T stage, N stage, and chemotherapy were the most significant features of the optimal model, and SHAP analysis identified their important contributions within the model.

conclusionWe have developed interpretable machine learning models to predict the OS of female bladder cancer patients following radical surgery. This model is intended to assist in clinical prognosis evaluation and provide a reference for individualized treatment decision-making.

Indexed as

Female bladder cancerMachine learningOverall survivalRadical cystectomySEER

Identifiers

PMID41455036
PMCPMC12852532

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.